Eric Lefkofsky is well known throughout the Greater Chicago area for being a serial entrepreneur who specializes in creating companies with high value. His major contribution is in the form of funding Tempus, a company built to address concerns and develop research into researching ways that lingo cancer develops. Eric Lefkofsky has achieved considerable success in his field and seeks to continue research and development towards a greater understanding of cancer, and steps towards identifying the environmental factors behind lung cancer.
There are currently 29 employees at Tempus working on progressing the field of cancer research. Many of them have worked in high profile jobs in the past and have joined Tempus to work on important projects. Eric Lefkofsky has contributed to the field of cancer research in more than a few ways and currently donates to multiple organizations such as University of Michigan, Stanford, and his own personal fund. These contributions place Eric Lefkofsky as a well respected and key figure in the fight against cancer.
The major breakthroughs have come in the form of understanding the nature of lung cancer and identifying SNPs (single-nucleotide polymorphisms) as well as the effective costs of human genome sequencing. The knowledge base increased in the past fifteen years has contributed exponentially to the field of cancer research. Since co-founding Tempus in 2016, Erik and his staff have been able to considerably advance research in the field of lung, breast, and pancreatic cancer. This has proven to be immeasurably important in the lives of people struggling with cancer. To know more about him click here.
The biggest barrier in cancer research that’s been crossed is the greater understanding of human genome sequencing and the lowered costs of developing and mapping a human genome. The costs have fallen substantially from over 100 million dollars per genome in 2003 to just under 500 dollars today. This sinking cost of genome sequencing contributes to the ongoing fight against cancer. Eric’s work has been instrumental in understanding and fighting lung cancer, and Tempus was built on that principle of improving human life.